Cherish Health develops intelligent radar-based sensor platforms that revolutionize health and safety monitoring. The technology works ambiently without changing how people live and prioritizes their privacy. Cherish Health detects emergencies and risks to people’s health and well-being and brings them timely help.

Cherish Health

Neural Propulsion Systems revolutionizes radar technology with patented algorithms that deliver unprecedented resolution, precision, and reliability, empowering vehicle operators to navigate complex road conditions.

Babak Hassibi

Behrooz Rezvani

Neural Propulsion Systems

Arbe Robotics Ltd., a semiconductor company, provides 4D imaging radar solutions for tier 1 automotive suppliers and automotive manufacturers in Israel and the United States. It offers 4D imaging radar chipset solutions that address the core issues that have caused autonomous vehicle and autopilot accidents, such as detecting stationary objects, identifying vulnerable road users, and eliminating false alarms without radar ambiguities. The company was founded in 2015 and is headquartered in Tel Aviv-Yafo, Israel.

Arbe Robotics Ltd.

Arralis develops millimeter wave technology and solutions for aerospace, defense, and security applications.

Metric
Company Name	Cherish Health	Neural Propulsion Systems	Arbe Robotics Ltd.	Arralis
Symbol			ARBE
MSH ID	COM:CHERISHHEALTH	AI:NPS	COM:ARBEROBOTICS	COM:ARRALIS
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	10	Technology	Technology
Industry	Health Technology	Technology	Software - Infrastructure	Aerospace & Defense Electronics
Country	US	US	IL	IE
Stage	Grant
Employee Count		24	137
Website	cherishhealth.com	nps.ai	arberobotics.com	arralis.com
LinkedIn		npsai
Founders

Metric
Market Cap			166.61M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue			1.47M
Revenue (LTM)
Revenue (NTM)
Gross Profit			-38K
EBITDA			-46.33M
Operating Income			-46.88M
Net Income			-43.50M
EPS			-0.60
Diluted EPS			-0.60
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.07
Operating Profit Margin			-31.89
EBITDA Margin			-31.52
Net Profit Margin			-29.09
Return on Equity			-0.86
Return on Assets			-0.72
Return on Capital Employed			-1.00

COM:CHERISHHEALTH

Cherish Health

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-3.43
P/B Ratio			2.99
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			151.17
EV Multiple			-2.62

Metric
Days Sales Outstanding			873.19
Days Payables Outstanding			182.35
Days Inventory Outstanding			0.00
Operating Cycle			873.19
Cash Conversion Cycle			690.84
Asset Turnover			0.03

Metric
Operating Cash Flow			-33.51M
Free Cash Flow			-33.76M
Cash Flow to Debt			-0.93
Operating Cash Flow/Sales			-21.74
Free Cash Flow Yield			-0.26

Metric
Cash & Equivalents			28.75M
Accounts Receivable			694K
Inventory
Goodwill
Debt to Capitalization			0.56
Debt to Assets			0.00
Current Ratio			10.09
Quick Ratio			10.07

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			9.31
R&D to Revenue			28.67
SG&A to Revenue			6.02